The Medibank (ASX:MPL) share price is up 18% so far in 2021. Here's why

Here's what's driven the Medibank share price this year.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price has been having a great year so far on the ASX.

Perhaps more impressive, the health insurance and solutions company's gains have come despite it only releasing news a handful of times.

Right now, the Medibank shares are trading for $3.54 apiece, 17.28% higher than they were at the start of 2021.

Let's take a closer look at what the S&P/ASX 200 Index (ASX: XJO) company has been up to in 2021.

What's driven the Medibank share price in 2021?

It's been a good year for Medibank shares, despite the company keeping relatively quiet. Here's what we've heard from Medibank in 2021.

Myhealth acquisition

In early February, Medibank announced it had acquired a non-controlling 33.4% interest in Myhealth Medical Group.

Myhealth operates 86 primary care clinics scattered across Victoria, New South Wales, and Queensland.

According to Medibank, the investment strengthened its focus on preventive health and doctor-led partnerships.

The Medibank share price didn't react to the news.

Half yearly results

A matter of weeks later, Medibank released its results for the first half of financial year 2021.

For the 6 months ended 31 December 2020, Medibank recorded net profits after tax of $226.4 million, a 27.3% increase on those of the prior corresponding period.

It also reported that its income from premiums rose 0.3% to $3.3 billion, while its net claims expenses dropped $24.1 million – or 0.8%.

Medibank also announced a 5.8 cent fully franked dividend.

Finally, the company announced its CEO, Craig Drummond, was to retire. Medibank's new CEO David Koczkar took over the role on 17 May.

The Medibank share price fell 3.4% on the back of the results.

Returning money to customers

Lastly, in April Medibank announced that it plans to return around $105 million it's saved during COVID-19 to its customers.

According to Medibank, the savings came from its customers deferring their claims due to the global pandemic.

The Medibank share price fell 0.6% the day the company announced the give-back.

Medibank share price snapshot

After starting 2021 at $3.04, the Medibank share price is now $3.54.

It has also gained 24% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »